Wolfram Group

Nanomedicine on the development of new strategies for the treatment of disease

Associate Professor Joy Wolfram’s research program in nanomedicine on the development of new strategies for the treatment of disease. In particular, her team is developing extracellular vesicle therapeutics and diagnostics for inflammatory conditions and cancer.

Nanotechnology enables the design of multifunctional and targeted strategies, thereby increasing therapeutic efficacy and reducing side effects. The ultimate goal of the research program is to bring new nanomedicines to clinical practice.